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In this issue of Immunity, Delogu et al. (2006) and Nera
et al. (2006) find that the downregulation of Pax-5 dur-
ing antigen-dependent-terminal differentiation results
in a substantial loss of B cell identity and the transi-
tion to a plasma cell state.
The transcription factor Pax-5 functions downstream of
the regulators E2A and EBF to reinforce B cell fate
choice by activating the expression of B lineage genes
such as mb-1, CD19, and BLNK (Busslinger, 2004; Singh
et al., 2005). Pax-5 also plays a crucial role in B cell fate
commitment by repressing the expression of alternate
lineage genes such as c-fms and Notch-1. Pax-52/2
pro-B cells, unlike their wild-type counterparts, are mul-
tipotent and can generate T, NK, and myeloid cell types.
Finally, conditional deletion of Pax-5 in committed pro-
B cells also results in the reversion to a multipotent state
from which T lymphocytes and macrophages can be
generated (Mikkola et al., 2002). This result suggests
that Pax-5 is continuously required to maintain B cell
identity. These analyses raise several important issues.
How large is the set of lineage-inappropriate genes that
are repressed by Pax-5? Are these genes actively re-
pressed by Pax-5, not only in committed pro B cells
but also in mature B cells? Finally, because the terminal
differentiation of B cells into plasma cells involves a sig-
nificant loss of B cell identity and is accompanied by the
downregulation of Pax-5, could Pax-5 also function to
repress the plasma cell gene expression program?
Two articles in this issue of Immunity experimentally ad-
dress these questions by examining the consequences
of deleting the Pax-5 gene in murine pro-B and mature
B cells and the chicken DT40 B cell line.
Busslinger and colleagues comprehensively analyze
Pax-5-repressed genes in pro-B cells by comparing
the gene-expression profiles of wild-type and Pax-52/2
pro-B cells by using a customized microarray. This anal-
ysis reveals a diverse set of 110 genes, many of which
are normally expressed in alternate lineages of the
hematopoietic system. The observation that a signifi-
cant number of myeloid genes are misexpressed in
Pax-52/2 pro-B cells prompted the authors to analyze
the expression pattern of myeloid genes in common
lymphoid progenitors (CLPs), which do not express sig-
nificant levels of Pax-5 and had previously been reported
to exhibit a lymphoid-restricted gene expression pattern
(Miyamoto et al., 2002). Delogu et al. (2006) observe that
CLPs like Pax-52/2 pro-B cells indeed express detect-
able myeloid gene transcripts and suggest that this ac-
counts for their latent myeloid potential. Thus, CLPs
can be viewed as early B lineage developmental inter-
mediates in the bone marrow that are in the process of
undergoing restriction in their myeloid versus B lineage
developmental potential.
To determine if Pax-5 is continuously required for re-
pression of alternate lineage genes, the authors examinethe consequences of Pax-5 loss in lymph node B cells,
using a conditional deletion strategy (CD19-cre). This
shows that alternate lineage genes such as Ccl3, Csf1r
(M-CSFR), and Fc3r1g require Pax-5 for their repression
in pro-B as well as B cells. Intriguingly, loss of Pax-5 in
B cells also results in the activation of genes that are re-
quired for and/or associated with plasma cell differenti-
ation, such as Prdm1 (Blimp-1), Igj (J chain), Cd28, and
Ccr2. Blimp-1 is an essential transcriptional regulator
of plasma cell differentiation (Shapiro-Shelef and Cal-
ame, 2005). Because Pax-5 expression is downregulated
during antigen-dependent terminal differentiation of ma-
ture B cells into immunoglobulin-secreting plasma cells,
this leads to the possibility that modulation of Pax-5 ex-
pression is an obligate event that controls the B to
plasma cell transition (Figure 1).
Does the continuous repression of lineage inappro-
priate and plasma cell genes by Pax-5 in pro-B and B
cells have functional consequences? The authors nicely
test both possibilities. Using a transgenic strategy, they
misexpress the Pax-5-repressed chemokine gene Ccl3
throughout B cell development. This results in enhanced
generation of osteoclasts and bone loss, suggesting that
Pax-5-dependent gene repression is required for ho-
meostasis within the hematopoietic system. Conversely,
the Pax-5-repressed genes Cd28 and Ccr2, which are
expressed in plasma cells, are shown to have cell intrin-
sic functions in postgerminal center B cells. Thus, the
continuous function of Pax-5 in actively repressing
genes during B cell development may have evolved from
the requirement to shed B cell identity during terminal
differentiation into plasma cells.
Nera et al. (2006) use the chicken DT40 B cell line to an-
alyze the functions of Pax-5. Deletion of both Pax-5 al-
leles results in reduced surface lgM expression and loss
of B cell receptor signaling. This is attributed to downre-
gulation of genes encoding Ig coreceptor and signaling
molecules such as Igb, BLNK, and Lyn. Importantly in
Pax-52/2 DT40 B cells, the plasma cell transcription
factors Blimp-1 and XBP-1 are induced, whereas the
germinal center transcriptional regulator Bcl-6 is down-
regulated. Consistent with these changes in the tran-
scriptional regulatory network, the mutant DT40 cells
secrete elevated levels of lgM. Thus, in this cell system,
deletion of Pax-5 results both in a loss of B cell identity
and a substantial transition to a plasma cell state. The lat-
ter is likely due to loss of Bcl-6 expression, as reexpres-
sion of Bcl-6 in Pax-52/2 B cells blocks the induction of
Blimp-1. These results lead the authors to suggest that
Pax-5 positively regulates B cell identity as well as the
germinal center B cell program, the latter by sustaining
the expression of Bcl-6. In this regard, Pax-5 also ap-
pears to positively regulate AID expression. After affinity
maturation and isotype switching, Pax-5 is down-
regulated, resulting in diminished expression of Bcl-6,
thereby enabling the induction of plasma cell transcrip-
tion factors Blimp-1 and XBP-1. In this regulatory model,
Pax-5 represses Blimp-1 indirectly via Bcl-6 (Figure 1).
Although these experiments analyzing Pax-5 function
in murine B cells and the avian DT40 cell line reinforce
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240Figure 1. A Model that Illustrates the Role of Pax5 in Maintaining B Cell Identity and in Repressing Plasma Cell Differentiation
During the antigen-independent phases of B cell differentiation, Pax5 sustains B cell identity by simultaneously activating genes necessary for
B cell function and repressing a large cohort of lineage inappropriate genes. After antigenic stimulation, Pax5 continues its roles in maintaining
B cell identity and upregulates the expression of Bcl-6 and AID, genes necessary for affinity maturation. Importantly, Pax5-induced expression of
Bcl-6 serves to repress the expression of Blimp-1 and, ultimately, plasma cell differentiation. In a plasma cell, Pax5 expression is turned off, in
part by Blimp-1, which leads to the loss of B cell identity. In addition, Blimp-1 represses the expression of Bcl-6, thus cementing the plasma cell
state necessary for efficient antibody secretion. Thus, the expression of Pax5 in B cells serves to preserve B cell functions necessary for efficient
immunity, whereas its dynamic downregulation during the conversion to a plasma cell allows Blimp-1 expression that results in a terminally
differentiated, antibody-secreting plasma cell.each other, they differ from the standpoint that loss of
Pax-5 in the latter system results in a more profound
transition to a plasma cell state. This is likely due to
the fact that although loss of Pax-5 in murine B cells re-
sults in enhanced levels of Blimp-1, it is not accompa-
nied by reduced expression of Bcl-6 or elevated levels
of XBP-1. The differences between the two systems
may reflect a species variation in the regulatory circuitry
or, alternatively, the fact that the DT40 cells reflect an
activated germinal center B cell state. According to
the latter view, the induction of physiological levels of
Blimp-1 expression may depend on both the downregu-
lation of Pax-5 as well as positive regulatory inputs from
the antigen and cytokine receptor signaling systems.
Thus, loss of Pax-5 at this later activated stage of B cell
development may account for the fuller transition to
a plasma cell state.
Nevertheless, both experimental systems demon-
strate that Pax-5 is continuously required for main-
taining B cell identity and repressing the plasma cell
program. Its downregulation at a late stage of antigen-
driven B cell differentiation results in loss of B cell iden-
tity and the emergence of the plasma cell state. Thus,
Pax-5 downregulation in addition to Bcl-6 degradation
(Niu et al., 1998) likely trigger the onset of plasma cell
differentiation, and it will be important to explorethe underlying regulatory pathways and molecular
mechanisms.
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